FIREFLY NEUROSCIENCE INC (AIFF)
US3179701012 - Common Stock
AIFF gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. Both the profitability and financial health of AIFF have multiple concerns. AIFF does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
AIFF had negative earnings in the past year.
AIFF had a negative operating cash flow in the past year.
In the past 5 years AIFF reported 4 times negative net income.
AIFF had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -36.21%, AIFF is not doing good in the industry: 62.16% of the companies in the same industry are doing better.
AIFF has a worse Return On Equity (-79.79%) than 62.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.21% | ||
| ROE | -79.79% | ||
| ROIC | N/A |
ROA(3y)-90.76%
ROA(5y)-58.36%
ROE(3y)-190.67%
ROE(5y)-121.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AIFF has a worse Gross Margin (34.42%) than 75.68% of its industry peers.
AIFF's Gross Margin has improved in the last couple of years.
AIFF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.24%
GM growth 5Y6.45%
2. Health
2.1 Basic Checks
AIFF does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIFF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AIFF has more shares outstanding
AIFF has a worse debt/assets ratio than last year.
2.2 Solvency
AIFF has an Altman-Z score of -8.20. This is a bad value and indicates that AIFF is not financially healthy and even has some risk of bankruptcy.
AIFF's Altman-Z score of -8.20 is on the low side compared to the rest of the industry. AIFF is outperformed by 83.78% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that AIFF is not too dependend on debt financing.
AIFF has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.2 |
ROIC/WACCN/A
WACC10.19%
2.3 Liquidity
AIFF has a Current Ratio of 0.76. This is a bad value and indicates that AIFF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.76, AIFF is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
A Quick Ratio of 0.76 indicates that AIFF may have some problems paying its short term obligations.
AIFF has a Quick ratio of 0.76. This is in the lower half of the industry: AIFF underperforms 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 92.56% over the past year.
Looking at the last year, AIFF shows a very negative growth in Revenue. The Revenue has decreased by -27.19% in the last year.
AIFF shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.22% yearly.
EPS 1Y (TTM)92.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.18%
Revenue 1Y (TTM)-27.19%
Revenue growth 3Y-16.88%
Revenue growth 5Y-2.22%
Sales Q2Q%-11.33%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
AIFF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for AIFF!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FIREFLY NEUROSCIENCE INC
NASDAQ:AIFF (1/13/2025, 8:01:24 PM)
Premarket: 4.19 +2.29 (+120.53%)1.9
-0.37 (-16.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners1.1%
Inst Owner Change0%
Ins Owners23.23%
Ins Owner Change100%
Market Cap16.15M
AnalystsN/A
Price TargetN/A
Short Float %6.12%
Short Ratio1.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.09 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 9.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.91
BVpS0.2
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.21% | ||
| ROE | -79.79% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.42% | ||
| FCFM | N/A |
ROA(3y)-90.76%
ROA(5y)-58.36%
ROE(3y)-190.67%
ROE(5y)-121.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.24%
GM growth 5Y6.45%
F-Score6
Asset Turnover2.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.76 | ||
| Altman-Z | -8.2 |
F-Score6
WACC10.19%
ROIC/WACCN/A
Cap/Depr(3y)22.22%
Cap/Depr(5y)153.33%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.19%
Revenue growth 3Y-16.88%
Revenue growth 5Y-2.22%
Sales Q2Q%-11.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y65.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.83%
OCF growth 3YN/A
OCF growth 5YN/A